GeoVax is a Georgia-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.Read more
$ < 1M
GeoVax's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 29.7B. Over the last three quarters, GeoVax's revenue has grown by 168.1%. Specifically, in Q1 2022's revenue was $ < 1M; in Q4 2021, it was $ < 1M; in Q3 2021, it was $ < 1M.